Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Non-Tamiflu Users Show Higher Incidence of Abnormal Behavior: Study Team Report
January 14, 2008
- ON THE MOVE／J&J Appoints D. W. Powell President
January 14, 2008
- Abnormal Behavior Reported in 38% of Patients Not Taking Tamiflu
January 14, 2008
- R&D NEWS IN BRIEF
January 14, 2008
- Nexavar, Licomodulin, Zevalin to Be Officially Approved Soon
January 14, 2008
- Korosho's General Account Budget to Total \22,117.9 Bil.
January 14, 2008
- Korosho to Promote the Use of Generics by Welfare Recipients
January 14, 2008
- Rules to Be Revised to Oblige Pharmacists to Dispense Generics: Mr Urushibata
January 14, 2008
- Only 16% of Consumers Ask Doctors for Generics Despite High Awareness Rate
January 14, 2008
- Teva to See Its First NHI Price Listing in 2008
January 14, 2008
- TOPICS／Novartis Pharma to Introduce New System to Improve MR Competence
January 14, 2008
- BUSINESS NEWS IN BRIEF
January 14, 2008
- MEDICAL DEVICE NEWS IN BRIEF
January 14, 2008
- Blopress Maintains No. 1 Position: Top 100 Drugs Ranking
January 14, 2008
- TOPICS／NBI Helps Employees Manage Work and Family Life
January 7, 2008
- REGULATORY NEWS IN BRIEF
January 7, 2008
- Patient-Centered Healthcare - 10 Concerns of Patients
January 7, 2008
- 54 New Drugs Approved in 1st Half of FY2007: PMDA
January 7, 2008
- AstraZeneca to Start PI for 20 Products in 2008, as in 2007: CEO D. Brennan
January 7, 2008
- 7 New Products Included in NHI Price List
January 7, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…